Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00264
Species: Homo sapiens
Position : chr12:2880430-3018116
Year: 2022
Title: A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  35390165
MONDO: MONDO:0006120
Tissue: Breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MCF-7
CVCL ID: CVCL_0031
Cell Type: breast carcinoma cell
Cell Ontology ID: CL:0000066
Experiment Type: Functional perturbation assay, Chromatin interaction assay, Enhancer activity assay
High Throughput Method: ChIP-seq, RNA-seq
Low Throughput Method: Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR, Western blot, 3C, FISH, EMSA, FRAP
About Target Gene
Target gene : FOXM1
About TF
TF name : YY1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
YY1 Activation of anterior HOX genes in hindbrain development during early embryogenesis reactome 120
YY1 DNA Damage Recognition in GG-NER reactome 38
YY1 E2F transcription factor network pid 77
YY1 mTOR signaling pathway pid 66
YY1 Notch-mediated HES/HEY network pid 48
YY1 Notch netpath 76
YY1 Notch signaling pathway pid 58
YY1 p53 pathway pid 59
YY1 Signaling events mediated by HDAC Class I pid 89
Enhancer Associated Network
Overlapping Enhancers (hg19) 4 found
Enhancer ID Position Tissue Cell Disease
E_00265 chr12:2880430-3018116 Bone osteosarcoma cell osteosarcoma
E_00266 chr12:2880430-3018116 Cervix cervical adenocarcinoma cell cervical cancer
E_00267 chr12:2880430-3018116 Embryonic Kidney embryonic kidney cell --
E_00268 chr12:2880430-3018116 Pancreatic islet pancreatic beta cell --
Expression of Target Genes for the Enhancer